Works matching IS 1869-6953 AND VI 14 AND IP 4 AND DT 2023

Results: 13

Malignant External Otitis: What the Diabetes Specialist Should Know—A Narrative Review.

Published in:

Diabetes Therapy, 2023, v. 14, n. 4, p. 629, doi. 10.1007/s13300-023-01390-9

By:

Tsilivigkos, Christos;
Avramidis, Konstantinos;
Ferekidis, Eleftherios;
Doupis, John

Publication type:

Article

Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System.

Published in:

Diabetes Therapy, 2023, v. 14, n. 4, p. 767, doi. 10.1007/s13300-023-01385-6

By:

Alva, Shridhara;
Brazg, Ronald;
Castorino, Kristin;
Kipnes, Mark;
Liljenquist, David R.;
Liu, Hanqing

Publication type:

Article

The Association Between Obesity and the 5-Year Prevalence of Morbidity and Mortality Among Adults with Type 2 Diabetes.

Published in:

Diabetes Therapy, 2023, v. 14, n. 4, p. 709, doi. 10.1007/s13300-023-01384-7

By:

Boye, Kristina S.;
Ford, Janet H.;
Thieu, Vivian T.;
Lage, Maureen J.;
Terrell, Kendra A.

Publication type:

Article

Development and Validation of a Distress Measurement Related to Glucose Monitoring of Diabetes Patients.

Published in:

Diabetes Therapy, 2023, v. 14, n. 4, p. 737, doi. 10.1007/s13300-023-01383-8

By:

Choi, Eujin;
Kim, Sooyeon;
Cho, Juhee;
Kim, Min-Sun;
Kwon, Eun Kyung;
Kim, Youngha;
Kang, Danbee;
Cho, Sung Yoon

Publication type:

Article

Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults with Type 2 Diabetes.

Published in:

Diabetes Therapy, 2023, v. 14, n. 4, p. 723, doi. 10.1007/s13300-023-01382-9

By:

Palanca, Ana;
Ampudia-Blasco, F. Javier;
Calderón, José Miguel;
Sauri, Inmaculada;
Martinez-Hervás, Sergio;
Trillo, José Luis;
Redón, Josep;
Real, José T.

Publication type:

Article

GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers.

Published in:

Diabetes Therapy, 2023, v. 14, n. 4, p. 777, doi. 10.1007/s13300-023-01381-w

By:

Heinla, Keiu;
Vasar, Eero;
Reppo, Ingrid;
Sedman, Tuuli;
Volke, Vallo

Publication type:

Article

The Effect of the COVID-19 Pandemic on HbA1c Testing: Prioritization of High-Risk Cases and Impact of Social Deprivation.

Published in:

Diabetes Therapy, 2023, v. 14, n. 4, p. 691, doi. 10.1007/s13300-023-01380-x

By:

Holland, David;
Heald, Adrian H.;
Hanna, Fahmy F. W.;
Stedman, Mike;
Wu, Pensée;
Sim, Julius;
Duff, Christopher J.;
Duce, Helen;
Green, Lewis;
Scargill, Jonathan;
Howe, Jonathon D.;
Robinson, Sarah;
Halsall, Ian;
Gaskell, Neil;
Davison, Andrew;
Simms, Mark;
Denny, Angela;
Langan, Martin;
Fryer, Anthony A.

Publication type:

Article

Impact of Type 2 Diabetes Duration on the Efficacy and Safety of Add-on Lixisenatide in Asian Individuals Receiving Basal Insulin: A Pooled Analysis.

Published in:

Diabetes Therapy, 2023, v. 14, n. 4, p. 653, doi. 10.1007/s13300-023-01369-6

By:

Yao, Jun;
Zhang, Minlu;
Zhang, Xia;
Zhang, Junqing

Publication type:

Article

Living with Type 2 Diabetes: Podcast of a Patient–Physician Discussion.

Published in:

Diabetes Therapy, 2023, v. 14, n. 4, p. 621, doi. 10.1007/s13300-023-01378-5

By:

Kushner, Pamela;
Dalin, Anne

Publication type:

Article

Correction to: Addendum 1: Forum for Injection Technique and Therapy Expert Recommendations, India.

Published in:

2023

By:

Kalra, Sanjay;
Unnikrishnan, Ambika G.;
Prasanna Kumar, K. M.;
Sahay, Rakesh;
Chandalia, Hemraj B.;
Saboo, Banshi;
Annamalai, Sundaram;
Kesavadev, Jothydev;
Shukla, Rishi;
Wangnoo, S. K.;
Baruah, Manash P.;
Jacob, Jubbin;
Arora, Saurabh;
Singla, Rajiv;
Sharma, Suresh K.;
Damodaran, Suresh;
Bantwal, Ganapathi

Publication type:

Correction Notice

Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis.

Published in:

Diabetes Therapy, 2023, v. 14, n. 4, p. 639, doi. 10.1007/s13300-023-01375-8

By:

Haluzík, Martin;
Seufert, Jochen;
Guja, Cristian;
Bonnemaire, Mireille;
Bigot, Gregory;
Tournay, Mathilde;
Kis, János Tibor;
Freemantle, Nick

Publication type:

Article

Use of iGlarLixi for the Management of Type 2 Diabetes in Japanese Clinical Practice: Prior Treatment Subgroup Analysis of the SPARTA Japan Study.

Published in:

Diabetes Therapy, 2023, v. 14, n. 4, p. 671, doi. 10.1007/s13300-023-01373-w

By:

Miyoshi, Hideaki;
Matsuhisa, Munehide;
Yabe, Daisuke;
Takahashi, Yoko;
Morimoto, Yukiko;
Terauchi, Yasuo

Publication type:

Article

A Randomized, Placebo-Controlled Crossover Study to Evaluate Postprandial Glucometabolic Effects of Mulberry Leaf Extract, Vitamin D, Chromium, and Fiber in People with Type 2 Diabetes.

Published in:

Diabetes Therapy, 2023, v. 14, n. 4, p. 749, doi. 10.1007/s13300-023-01379-4

By:

Mohamed, Mafauzy;
Zagury, Roberto Luis;
Bhaskaran, Kalpana;
Neutel, Joel;
Mohd Yusof, Barakatun Nisak;
Mooney, Linda;
Yeo, Lihe;
Kirwan, Bridget-Anne;
Aprikian, Olivier;
von Eynatten, Maximilian;
Johansen, Odd Erik

Publication type:

Article